Remarkable effect of milnacipran in the treatment of Japanese major depressive patients [1]

Human Psychopharmacology

Volumn 17, Issue 4, 2002, Pages 195-196

  Higuchi, Hisashi ^a   Yoshida, Keizo ^b   Takahashi, Hitoshi ^b   Naito, Shingo ^b   Tsukamoto, Kei ^b   Kamata, Mitsuhiro ^b   Ito, Kenichi ^b   Sato, Kazuhiro ^b   Shimizu, Tetsuo ^b  

^a Omagari City Hospital   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROTIZOLAM; MILNACIPRAN; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ADRENERGIC RECEPTOR AFFECTING AGENT; CYCLOPROPANE DERIVATIVE;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MARKETING; DRUG RESPONSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; JAPAN; LETTER; MALE; PRIORITY JOURNAL; RATING SCALE; BLOOD; CLINICAL TRIAL; MAJOR DEPRESSION; MIDDLE AGED; TREATMENT OUTCOME;

ADRENERGIC UPTAKE INHIBITORS; CYCLOPROPANES; DEPRESSION, INVOLUTIONAL; FEMALE; HUMAN; JAPAN; MALE; MIDDLE AGE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; DEPRESSIVE DISORDER, MAJOR; HUMANS; MIDDLE AGED;

EID: 0035989054     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.392     Document Type: Letter

References (3)

1. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: A summary of clinical trial results
2. Multiple and single dose pharmacokinetics of milnacipran in major depressive patients